Planned maintenance

We must perform activities that will impact the ability to place orders on our website. Starting Friday, May 21, at 5:00 p.m. Eastern to Sunday, May 23, at 5:00 p.m. Eastern, you will not be able to order products on our website. You will still be able to browse atcc.org and access your account. We apologize for any inconvenience this work may cause.
X

Carbapenem-resistant Enterobacteriaceae (CRE): A Growing Superbug Population

Carbapenem-resistant Enterobacteriaceae (CRE): A Growing Superbug Population

The discovery of antibiotics in the early twentieth century has revolutionized the treatment of infectious diseases, saving millions of lives and easing the suffering of many. However, as the structure and function of antibiotics have evolved through the efforts of biotech and pharma companies, prokaryotic species are evolving in parallel, fashioning novel and effective methods to avoid therapeutic killing. In the last several decades, this concern has become more pronounced with the emergence of multidrug-resistant organisms in both community- and hospital-acquired infections, resulting in increased morbidity, mortality, and health-care expense. In this presentation, we will discuss the emergence of multidrug-resistant infections with a particular emphasis on the emergence and global spread of carbapenem-resistant Enterobacteraeae strains.